Clinical Trial Update: Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA) [Phase 1]

View source ↗

Summary

Phase 1 study (CHMI-SIKA) assessing controlled human malaria infection in semi-immune Kenyan adults; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1 | Status: UNKNOWN